.Genentech will certainly shut its own cancer cells immunology study department, as well as unit min...
.Kezar Life Sciences is dropping its unpromising phase 1 strong lump drug as the biotech goes all-in...
.Regardless of izokibep sustaining its own newly found winning touch in the clinic, Acelyrin is no l...
.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing drug cand...
.Ovid Rehab already uncovered last month that it was actually trimming back its own head count as th...
.Eli Lilly has actually opened a $700 thousand R&D facility in the Boston Port, increasing its RN...
.Just five months after safeguarding a $one hundred thousand IPO, Boundless Bio is actually laying o...
.The preliminary stages of oncology R&D may not be short of fascinating brand new modalities, and...
.Psychopharmacology has pulled 3 posts about midstage professional test data examining Lykos Therape...
.Avidity Biosciences impressed entrepreneurs along with period 1/2 data in Duchenne muscle dystrophy...